About Us
Pangaea Global AIDS Foundation is a non-profit consulting organization dedicated to ending the pandemic and human suffering caused by HIV/AIDS. Pangaea specializes in developing and executing HIV/AIDS treatment and prevention strategies focused on settings with insufficient healthcare capacity and large or underserved HIV+ populations.
Pangaea works through public and private partnerships with entities engaged in large scale HIV/AIDS treatment delivery such as national health ministries, NGOs, universities, foundations and corporations. Using existing healthcare systems as a starting point, Pangaea works with in-country partners to strengthen infrastructure and systems of care and to develop new treatment capacity and treatment-based HIV prevention as needed.
Team
Pangaea staff members have been leaders in the field of HIV/AIDS in the United States and globally for over 25 years. Pangaea operates through a core group of senior staff and a network of consultants. With a combination of expertise in medicine, HIV prevention programming, national policy, epidemiology, and high-level management capability, Pangaea staff members have strong expertise in identifying gaps in existing healthcare systems and prevention strategies for high risk populations, enabling them to recommend long-term solutions, and work closely with partners to successfully scale up or establish new HIV/AIDS treatment capacity and prevention programs for vulnerable populations.
Pangaea has senior expertise in the following areas:
|
Clinical care
|
Infectious diseases, current HIV and TB treatment regimes, drug substitution therapy, and clinical disease monitoring
|
|
Lab Diagnostics
|
HIV diagnosis, HIV viral monitoring, low cost diagnostic options
|
|
Disease Surveillance
|
Rapid assessment methodologies, epidemiological monitoring and analysis
|
|
Monitoring & Evaluation
|
Program, national plans, population-specific initiatives
|
|
Health Care Worker Training
|
Didactic training and clinical mentoring for doctors, nurses, counselors and lay-providers, including community outreach workers and peer educators
|
|
Policy & Planning
|
National, regional and project specific
|
|
Health Systems
|
Clinic systems design – including patient information systems, patient flow, data management; care delivery infrastructure
|
|
Treatment-Linked Prevention
|
Programs for vulnerable women and youth – enabling reduction of vulnerabilities and high risk behaviors associated with HIV AIDS treatment for this population
|
Core Services
Pangaea’s core competencies support our work in the areas of treatment delivery systems, health care provider capacity building, and prevention for underserved sub-populations affected by HIV/AIDS.
To ensure that its work is effective and sustainable, Pangaea is committed to working through in-country partners and enhancing existing programs, clinical infrastructure, and national plans for HIV prevention and treatment. Pangaea services include the provision of technical assistance or project development and implementation in the following areas:
Health care systems and public health
- Establishing new HIV treatment programs and clinical services for both public and private entities at the national, regional and local level – government health care services and health care programs for private sector companies.
- Utilizing existing treatment infrastructure, building new capacity to provide a continuum of HIV treatment services and/or strengthening public health care systems to incorporate HIV services.
- HIV-TB linkages between services sites that maximize identification, diagnosis and treatment of HIV-TB co-infected populations.
- Enhancing laboratory-based diagnostics for clinical monitoring of HIV.
- Creating national government-led HIV/AIDS/TB treatment plans.
- Design of HIV prevention initiatives for implementation within a treatment context.
- Enhancing the capacity of community-based entities to implement prevention, care and treatment activities.
- Construction, fiscal and program management of treatment centers.
- Epidemiological disease surveillance in at-risk populations.
Specific underserved sub-populations
- Injection drug users – development of treatment and prevention programs including drug substitution therapy, combined HIV and drug treatment services, and a full range of harm reduction activities.
- Incarcerated populations – development of treatment and prevention programs dealing with HIV, TB infections and substance use issues, and linkage to on-going treatment and support post-release.
- Commercial sex workers – creation of flexible treatment programs for STI, HIV, TB diagnosis and treatment
- Girls and women – development of programs in HIV prevention and treatment, reproductive health, and women and children.
- Men having sex with men (MSM) - development of innovative HIV testing and prevention strategies in highly non-supportive cultural contexts; creation or strengthening access to medical services.
Health Care Providers
- Developing treatment guidelines and resources to ensure the delivery of comprehensive quality care including a focus on antiretroviral therapy; TB; Hepatitis B/C co infections; opportunistic infections; and drug substitution therapy.
- Training and on-going clinical mentoring of doctors, nurses and healthcare management personnel.
- Development of medical and nursing curricula in HIV/AIDS, TB and drug substitution therapy.
- Forming linkages between facility-based medicine and community- based extensions of care and treatment; structuring effective referral mechanisms to increase patient retention in care treatment outcomes.
History
Pangaea Global AIDS Foundation was founded in 2001 by the San Francisco AIDS Foundation in response to the global imperative to expand access to HIV/AIDS care and treatment in resource limited settings and mid-level economies. Based in San Francisco, California, Pangaea established a core team with depth in clinical HIV/AIDS, health care provider training, policy development, national level HIV/AIDS strategic planning and implementation, monitoring and evaluation, and program and fiscal management.
Pangaea’s early work focused on broadening access to HIV antiretroviral therapy in resource limited settings with projects in Rwanda, South Africa and Uganda. Working with various partners, Pangaea was involved in the development of early HIV/AIDS treatment sites in resource constrained settings and assisted national health ministries in the development of country-wide AIDS treatment plans.
While continuing work in Africa, Pangaea has broadened its efforts to include the planning and implementation of large scale treatment access projects in Asia and Eastern Europe, with special emphasis on HIV epidemics fueled by injection drug use. Pangaea also has special expertise working with the private sector to maximize HIV/AIDS prevention and treatment efforts, including the creation of a model clinic and training center funded by Pfizer Inc at Makerere University in Kampala, Uganda and the planning and implementation of a worldwide employee HIV/AIDS training and treatment program for Chevron Corp.
More recently Pangaea has expanded its focus to include work on HIV/TB treatment-based prevention strategies and greater emphasis on prevention and treatment program development for high risk populations, including injection drug users (IDUs), MSMs, and women.
Financial Information
Independent Auditors' Reports